Bidil Tablet, Film Coated
Product Images NDC 24338-010

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Bidil (NDC 24338-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Bidil 01)

FDA Label Image

Chemical Structure (Bidil 02)

FDA Label Image

Figure 1 (Bidil 03)

Figure 1 (Bidil 03)
The text describes a Kaplan-Meier plot of Time to Death by All Cause in Black Patients (A-HeFT). The plot show data points for Placebo and also mentions a Log-Rank Test. The axis shows the Time (Days) and the number of patients who are alive. The text also shows some numeric values for Placebo.*
FDA Label Image

Figure 2 (Bidil 04)

Figure 2 (Bidil 04)
This is a Kaplan-Meier plot of time to the first hospitalization for heart failure in black patients using BiDil compared to placebo, showing a 39% risk reduction in the first hospitalization for heart failure. The x-axis represents the time in days, while the y-axis shows the percent of patients without hospitalization. The plot demonstrates that BiDil reduces the risk of heart failure hospitalization significantly compared to the placebo group.*
FDA Label Image

Figure 3 (Bidil 05)

Figure 3 (Bidil 05)
The figure shows the change in Minnesota Living score with Heart Failure. Unfortunately, the rest of the text is not-readable or garbled.*
FDA Label Image

Figure 4 (Bidil 06)

FDA Label Image

Principal Display Panel (180 Tablet Bottle Label)

Principal Display Panel (180 Tablet Bottle Label)
This is a description of a medication called BiDil. The medication comes as 90 tablets in a bottle with an NDC code of 24338-010-09. The tablets contain a combination of isosorbide dinitrate and hydralazine hydrochloride (20mg and 3765mg, respectively). The medication should be stored at room temperature between 15°C - 30°C (59°F - 86°F). The rest of the text seems to be unreadable.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.